Vorotylov A.A., Mikhailova Z.D.
Features of kidney damage in metabolic syndrome
|
№2 / 2023
|
Bachmakov I.E., Fedoseev A.N., Denisova V.E.
Insulin resistance in chronic kidney disease
|
№4 / 2022
|
S.S. Allazova, M.S. Novikova, O.N. Kotenko, E.M. Shilov
Comparison of risk factors for developing post-transplant diabetis mellitus in patients with kidney allograft
|
№1 / 2020
|
V.Yu. Perfil'ev, Ya.F. Zverev, A.Yu. Zharikov
Insulin resistance as a risk factor for the development of uric acid nephrolithiasis
|
№1 / 2017
|
Ja.F. Zverev, V.M. Brjuhanov
Modern view on mechanisms of uric acid nephrolithiasis
|
№5-6 / 2015
|
N.V. Zagorodnikova, O.N. Rzhevskaya, K.E. Lazareva, N.V. Shmarina, A.V. Pinchuk
Prevalence of metabolic syndrome in early perioperative period after renal tranplantation
|
№3 / 2013
|
E.M. Shilov, E.I. Levankovskaya, M.S. Novikova
New approaches in treatment of chronic kidney disease in metabolic syndrome
|
№2 / 2012
|
E.A. Saginova, M.M. Severova, M.G. Galliamov, N.V. Ermakov, A.V. Rodina, V.V. Fomin, N.A. Moukhin
Clinical sighnificance of adiponectinemia in development of target organ-damage in metabolic syndrome, associated with non-alcoholic fatty liver disease
|
№6 / 2011
|
M.M. Severova, E.A. Saginova, M.G. Gallyamov, N.V. Ermakov, A.V. Rodina, M.V. Severov, V.V. Fomin, N.A. Moukhin
Association of leptinemia and adiponectinemia with chronic kidney disease in patients with metabolic syndrome and non-alcoholic fatty liver disease
|
№1 / 2011
|